SCHEMBL23367206

SCHEMBL23367206

CCOC(=O)c1nc(C(=O)OCc2ccccc2)no1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.49
BMP1 P13497 1/20 0.49
SLC26A6 Q9BXS9 4/20 0.48
CES1 P23141 1/20 0.48
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 3/20 0.46
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
ADORA3 P0DMS8 1/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23367202 0.86 ALDH1A1 (0.50) MMP2CES1RAB9ANPC1KMT2A
SCHEMBL18927560 0.83 POLB (0.54) MMP2BMP1SLC26A6RAB9AKMT2A
SCHEMBL19975800 0.83 TDP1 (0.54) CES1RAB9ANPC1KMT2AHTT
SCHEMBL553588 0.78 KLKB1 (0.49) SLC26A6RAB9ANPC1KMT2AHTT
SCHEMBL892934 0.78 MMP2 (0.51) MMP2BMP1SLC26A6RAB9ANPC1
SCHEMBL19465373 0.77 MMP2 (0.50) MMP2BMP1RAB9AKMT2ASLC6A2
SCHEMBL22624524 0.77 TDP1 (0.46) CES1RAB9ANPC1KMT2ASLC6A2
SCHEMBL6601253 0.76 MMP2 (0.57) MMP2BMP1SLC26A6RAB9ANPC1
SCHEMBL20278723 0.76 L3MBTL1 (0.50) RAB9ANPC1KMT2AHTTSLC6A2
SCHEMBL13733197 0.75 HTT (0.49) SLC26A6CES1RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
WO-2021094434-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 MMP2 108/4885BMP1 829/4885SLC26A6 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.